Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, et al. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score >/= 50. J Clin Oncol 2021 Apr 19:JCO2100174. doi: 10.1200/JCO.21.00174.
PMID: 33872070


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016